Ilya Golovkin

Mr. Ilya Golovkin

V.I. Vernadsky Crimean Federal University
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
N(Nadezhda Otstavnykh (Chernysheva)
Nadezhda Otstavnykh (Chernysheva)
EBEvgeniya Bystritskaya
Evgeniya Bystritskaya
ASAnna Stenkova
Anna Stenkova
IGIlya Golovkin
Ilya Golovkin
ONOlga Nedashkovskaya
Olga Nedashkovskaya
MIMarina Isaeva
Marina Isaeva
We obtained two novel draft genomes of type Zobellia strains with estimated genome sizes of 5.14 Mb for Z. amurskyensis KMM 3526Т and 5.16 Mb for Z. laminariae KMM 3676Т. Comparative genomic analysis has been carried out between obtained and known genomes of Zobellia representatives. The pan-genome of Zobellia genus is composed of 4853 orthologous clusters and the core genome was estimated at 2963 clusters. The genus CAZome was represented by 775 GHs classified into 62 families, 297 GTs of 16 families, 100 PLs of 13 families, 112 CEs of 13 families, 186 CBMs of 18 families and 42 AAs of six families. A closer inspection of the carbohydrate-active enzyme (CAZyme) genomic repertoires revealed members of new putative subfamilies of GH16 and GH117, which can be biotechnologically promising for production of oligosaccharides and rare monomers with different bioactivities. We analyzed AA3s, among them putative FAD-dependent glycoside oxidoreductases (FAD-GOs) being of particular interest as promising biocatalysts for glycoside deglycosylation in food and pharmaceutical industries.

Verified
Journal Article
Open access
PDF file
Vol V. OberemokVol V. Oberemok
Vol V. Oberemok
RURefat Zhevdetovich Useinov
Refat Zhevdetovich Useinov
Oleksii SkorokhodOleksii Skorokhod
Oleksii Skorokhod
Nikita V. Gal'chinskyNikita V. Gal'chinsky
Nikita V. Gal'chinsky
INIlya Alexandrovich Novikov
Ilya Alexandrovich Novikov
YPYury Vladimirovich Plugatar
Yury Vladimirovich Plugatar
Insects vastly outnumber us in terms of species and total biomass, and are among the most efficient and voracious consumers of plants on the planet. As a result, to preserve crops, one of the primary tasks in agriculture has always been the need to control and reduce the number of insect pests. The current use of chemical insecticides leads to the accumulation of xenobiotics in ecosystems and a decreased number of species in those ecosystems, including insects. Sustainable development of human society is impossible without useful insects, so the control of insect pests must be effective and selective at the same time. In this article, we show for the first time a natural way to regulate the number of insect pests based on the use of extracellular double-stranded DNA secreted by the plant Pittosporum tobira. Using a principle similar to one found in nature, we show that the topical application of artificially synthesized short antisense oligonucleotide insecticides (olinscides, DNA insecticides) is an effective and selective way to control the insect Coccus hesperidum. Using contact oligonucleotide insecticide Coccus-11 at a concentration of 100 ng/μL on C. hesperidum larvae resulted in a mortality of 95.59 ± 1.63% within 12 days. Green oligonucleotide insecticides, created by nature and later discovered by humans, demonstrate a new method to control insect pests that is beneficial and safe for macromolecular insect pest management.

Verified
Journal Article
Open access
PDF file
TMTatyana Makalish
Tatyana Makalish
IGIlya Golovkin
Ilya Golovkin
Vol V. OberemokVol V. Oberemok
Vol V. Oberemok
KLKateryna Laikova
Kateryna Laikova
ZTZenure Temirova
Zenure Temirova
Anatolii V KubyshkinAnatolii V Kubyshkin
Anatolii V Kubyshkin
The urgency of the search for inexpensive and effective drugs with localized action for the treatment of rheumatoid arthritis continues unabated. In this study, for the first time we investigated the Cytos-11 antisense oligonucleotide suppression of TNF-α gene expression in a rat model of rheumatoid arthritis induced by complete Freund’s adjuvant. Cytos-11 has been shown to effectively reduce peripheral blood concentrations of TNF-α, reduce joint inflammation, and reduce pannus development. The results achieved following treatment with the antisense oligonucleotide Cytos-11 were similar to those of adalimumab (Humira®); they also compared favorably with those results, which provides evidence of the promise of drugs based on antisense technologies in the treatment of this disease.

Verified
Journal Article
Open access
PDF file
KYKseniya A. Yurchenko
Kseniya A. Yurchenko
KLKateryna Laikova
Kateryna Laikova
IGIlya Golovkin
Ilya Golovkin
INIlya Alexandrovich Novikov
Ilya Alexandrovich Novikov
AYAlyona Yurchenko
Alyona Yurchenko
Vol V. OberemokVol V. Oberemok
Vol V. Oberemok
In terms of the incidence among all tumors, skin cancer is on top, with the most deadly among them being melanoma. The search for new therapeutic agents to combat melanoma is very relevant. In our opinion, antisense oligonucleotides (ASO) aimed at suppressing the genes responsible for their viability in cancer cells give hope for treatment, which makes it possible to eliminate cancer cells near the tumor site both before and after surgery. In this article, we describe how Skeen-11 phosphorothioate oligonucleotide significantly decreased the proliferative activity of murine melanoma cells. Injections of Skeen-11 also inhibited tumor growth in mice with inoculated melanoma. A toxicity study showed no side effects with dose adjustments. The results show that the use of ASO Skeen-11 in vivo reduced the tumor size within 7 days, reduced the number of mitoses in the tumor cells, and increased the amount of necrosis compared with the control group.

14 December 2023 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
EZEvgeniya Zyablitskaya
Evgeniya Zyablitskaya
AKA. V. Kubyshkin
A. V. Kubyshkin
LSL. E. Sorokina
L. E. Sorokina
ASA. V. Serebryakova
A. V. Serebryakova
KAK. A. Aliev
K. A. Aliev
ЕЗЕ. Ю. Зяблицкая
Е. Ю. Зяблицкая
The dynamic relationships between tumor cells and their microenvironment are of crucial importance in the development and progression of the malignant process. Given the multifunctional potential of heterogeneous populations surrounding a tumor, targeting components of the microenvironment has long been regarded as a promising strategy in modern anticancer therapy. This review discusses the role of the components of the cellular microenvironment in carcinogenesis, analyzes in detail the main ways and mechanisms of action on the main cell populations, which are of the greatest interest in the context of the development of innovative anticancer therapy.

10 December 2023 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
MKMargarita A. Kalfa
Margarita A. Kalfa
IGIlya Golovkin
Ilya Golovkin
ALArtem E. Lazarev
Artem E. Lazarev
LGLena P. Golubinskaya
Lena P. Golubinskaya
OGOlga Yu. Gritskevich
Olga Yu. Gritskevich
ЗЮЗяблицкая Евгения Юрьевна
Зяблицкая Евгения Юрьевна
Ovarian cancer (OC) is a common malignancy of the female reproductive system. In most patients, OC is diagnosed in the later stages, leading to an abysmal prognosis. The standard treatment for OC is surgery and chemotherapy; however, relapse often occurs after treatment, especially in patients with advanced disease. New therapeutic options based on advances in tumor genetics and molecular biology are needed to improve treatment outcomes. Manipulations with genes and the proteins they express, affecting oncogenesis and treatment resistance, seem promising, and proteins and gene fragments identified using molecular methods become valuable markers in the supportive pharmacodiagnosis and tailoring of complex therapy. This article describes the research achievements in genetic markers in OC.